Cleared Special

K082150 - MODIFICATION TO PAXGENE BLOOD RNA SYSTEM (FDA 510(k) Clearance)

Feb 2009
Decision
189d
Days
Class 2
Risk

K082150 is an FDA 510(k) clearance for the MODIFICATION TO PAXGENE BLOOD RNA SYSTEM. This device is classified as a System, Blood Collection, Rna Stabilization, Rna Purification, Rt-pcr Molecular Diagnostic Test (Class II - Special Controls, product code NTW).

Submitted by Preanalytix GmbH (Franklin Lakes, US). The FDA issued a Cleared decision on February 4, 2009, 189 days after receiving the submission on July 30, 2008.

This device falls under the Pathology FDA review panel. Regulated under 21 CFR 866.4070. System For Collection, Storage, And Transport Of Whole Blood And Stabilization Of Intracellular Rna With Subsequent Isolation And Purification Of Host Rna For Rt-pcr Used In Molecular Diagnostic Testing.

Submission Details

510(k) Number K082150 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 30, 2008
Decision Date February 04, 2009
Days to Decision 189 days
Submission Type Special
Review Panel Pathology (PA)
Summary Summary PDF

Device Classification

Product Code NTW - System, Blood Collection, Rna Stabilization, Rna Purification, Rt-pcr Molecular Diagnostic Test
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.4070
Definition System For Collection, Storage, And Transport Of Whole Blood And Stabilization Of Intracellular Rna With Subsequent Isolation And Purification Of Host Rna For Rt-pcr Used In Molecular Diagnostic Testing